Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.

Strack AM, Carballo-Jane E, Wang SP, Xue J, Ping X, McNamara LA, Thankappan A, Price O, Wolff M, Wu TJ, Kawka D, Mariano M, Burton C, Chang CH, Chen J, Menke J, Luell S, Zycband EI, Tong X, Raubertas R, Sparrow CP, Hubbard B, Woods J, O'Neill G, Waters MG, Sitlani A.

J Lipid Res. 2013 Jan;54(1):177-88. doi: 10.1194/jlr.M031344. Epub 2012 Oct 28.

2.

Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans.

Song WL, Stubbe J, Ricciotti E, Alamuddin N, Ibrahim S, Crichton I, Prempeh M, Lawson JA, Wilensky RL, Rasmussen LM, Puré E, FitzGerald GA.

J Clin Invest. 2012 Apr;122(4):1459-68. doi: 10.1172/JCI59262. Epub 2012 Mar 12.

3.

Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.

Cheng K, Wu TJ, Wu KK, Sturino C, Metters K, Gottesdiener K, Wright SD, Wang Z, O'Neill G, Lai E, Waters MG.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6682-7. Epub 2006 Apr 14.

4.

Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.

Mateuszuk L, Jasztal A, Maslak E, Gasior-Glogowska M, Baranska M, Sitek B, Kostogrys R, Zakrzewska A, Kij A, Walczak M, Chlopicki S.

J Pharmacol Exp Ther. 2016 Feb;356(2):514-24. doi: 10.1124/jpet.115.228643. Epub 2015 Dec 2.

PMID:
26631491
5.

GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM, Moers A, Pfeffer K, Offermanns S.

J Clin Invest. 2005 Dec;115(12):3634-40.

6.

Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.

Strasky Z, Vecerova L, Rathouska J, Slanarova M, Brcakova E, Kudlackova Z, Andrys C, Micuda S, Nachtigal P.

Circ J. 2011;75(7):1747-55. Epub 2011 May 17.

7.

Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.

Kawashiri M, Zhang Y, Usher D, Reilly M, Puré E, Rader DJ.

J Lipid Res. 2001 Jun;42(6):943-50.

8.

Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.

Yoshikawa T, Shimano H, Chen Z, Ishibashi S, Yamada N.

Horm Metab Res. 2001 Aug;33(8):472-9.

PMID:
11544561
9.

Imaging of lipids in atherosclerotic lesion in aorta from ApoE/LDLR-/- mice by FT-IR spectroscopy and Hierarchical Cluster Analysis.

P Wrobel T, Mateuszuk L, Chlopicki S, Malek K, Baranska M.

Analyst. 2011 Dec 21;136(24):5247-55. doi: 10.1039/c1an15311k. Epub 2011 Oct 17.

PMID:
22007352
10.

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

Morgantini C, Imaizumi S, Grijalva V, Navab M, Fogelman AM, Reddy ST.

Diabetes. 2010 Dec;59(12):3223-8. doi: 10.2337/db10-0844. Epub 2010 Sep 8.

11.

Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.

Han SG, Howatt DA, Daugherty A, Gairola CG.

Toxicology. 2012 Sep 28;299(2-3):133-8. doi: 10.1016/j.tox.2012.05.015. Epub 2012 Jun 1.

PMID:
22659316
12.
13.

Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.

Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.

Biochem Biophys Res Commun. 2004 Apr 23;317(1):223-9.

PMID:
15047172
14.

Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.

Li MW, Mian MO, Barhoumi T, Rehman A, Mann K, Paradis P, Schiffrin EL.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2306-15. doi: 10.1161/ATVBAHA.113.302028. Epub 2013 Jul 25.

15.

Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.

Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.

Circ Res. 2009 Sep 25;105(7):686-95, 19 p following 695. doi: 10.1161/CIRCRESAHA.107.168799. Epub 2009 Aug 20.

16.

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.

Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):742-8. doi: 10.1161/ATVBAHA.109.201095. Epub 2010 Jan 28.

17.

Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.

Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2333-40.

19.
20.

Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.

Bogachev O, Majdalawieh A, Pan X, Zhang L, Ro HS.

Mol Med. 2011 Sep-Oct;17(9-10):1056-64. doi: 10.2119/molmed.2011.00141. Epub 2011 Jun 14.

Items per page

Supplemental Content

Write to the Help Desk